论文信息 - Refractory ITP in a patient with Kabuki syndrome: response to low-dose rituximab - 字舞流文

Refractory ITP in a patient with Kabuki syndrome: response to low-dose rituximab

J. Quinn | P. Murphy | B. Kerr

[1] P. Giordano,et al. Autoimmune haematological disorders in two Italian children with Kabuki Syndrome , 2014, Italian Journal of Pediatrics.

[2] N. Niikawa,et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome , 2013, American journal of medical genetics. Part A.

[3] R. Fanin,et al. Low‐dose rituximab in adult patients with primary immune thrombocytopenia , 2010, European journal of haematology.

[4] S. Kojima,et al. Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome , 2009, International journal of hematology.

[5] S. Amadori,et al. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. , 2008, Blood.

[6] S. Amadori,et al. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults , 2007, Haematologica.

[7] E. Zackai,et al. Immune abnormalities are a frequent manifestation of Kabuki syndrome , 2005, American journal of medical genetics. Part A.

[8] E. Zackai,et al. Autoimmune disorders in Kabuki syndrome , 2005, American journal of medical genetics. Part A.

[9] L. Hudgins,et al. Kabuki syndrome: a review , 2004, Clinical genetics.

[10] R. Pagon,et al. Phenotypic spectrum and management issues in Kabuki syndrome. , 1999, The Journal of pediatrics.

[11] J. Bussel,et al. Hemostasis, Thrombosis, and Vascular Biology , 2004 .